Fundz Deep Dive
Everything you need to win Vandria — in one platform.
Who to reach, what to say, and why now on Vandria — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Vandria — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing for Mitophagy Inducer VNA-318
Aug 21, 2024•almost 2 years ago
Contract Type
partnership
Description
Vandria SA announced the second closing of its Series A financing bringing the final amount raised to date to $30.7M (CHF28.3M). Hevolution Foundation and Dolby Family Ventures joined the lead founding venture investor ND Capital to support the development of the Mitophagy Inducer VNA-318 into CNS Clinical Development.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months